Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL
Jayappa, Kallesh D., Portell, Craig A., Gordon, Vicki L., Capaldo, Brian J., Bekiranov, Stefan, Axelrod, Mark J., Brett, L. Kyle, Wulfkuhle, Julia D., Gallagher, Rosa I., Petricoin, Emanuel F., BenderТом:
1
Журнал:
Blood Advances
DOI:
10.1182/bloodadvances.2016004176
Date:
June, 2017
Файл:
PDF, 2.40 MB
2017